Health ❯ Healthcare ❯ Medical Treatments

Cancer Treatments

Immunotherapy Bladder Cancer CAR T-cell Therapy Prostate Cancer Breast Cancer CAR-T Therapy CAR T Cell Therapy CAR-T Cell Therapy Gene Therapy Endometrial Cancer

UCSF-Led Study Engineers CAR-T Cells In Vivo, Clearing Tumors in Mice

Researchers say the preclinical method now requires scaling followed by human trials.

Treating Advanced Lung Cancer Before 3 p.m. Extends Survival in Phase III Trial

First Pivotal Trial Finds Cooled-Laser Prostate Therapy Effective at 3 Months With Low Morbidity

NICE Backs Talazoparib–Enzalutamide for NHS Use in England

First NHS Patient Completes Next‑Generation CAR‑T Therapy for Aggressive Leukaemia

FDA Approves Rybrevant Faspro, a 5‑Minute Subcutaneous Amivantamab for EGFR‑Mutated Lung Cancer

Lancet Phase III Trial Finds Proton Therapy Improves 5-Year Survival in Oropharyngeal Cancer

EMA Panel Backs Conditional EU Approval for Anktiva in BCG-Unresponsive Bladder Cancer

Base-Edited Donor CAR-T Yields 82% Transplant-Eligible Remission in Early T-Cell Leukemia Trial

UK Trial’s Base-Edited Off-the-Shelf CAR T Cells Deliver Durable Remissions in T-Cell Leukemia

Base-Edited Donor T Cells Induce Remissions in T-Cell Leukemia, NEJM Study Reports

FDA Approves Breyanzi for Marginal Zone Lymphoma After Two or More Therapies

NICE Backs Papillon X‑Ray Therapy for Eligible Rectal Cancer Patients on the NHS

NICE Backs Obe-cel for Adults With Aggressive Leukaemia as NHS Fast-Tracks Rollout

Vaccimel, Argentina's Melanoma Immunotherapy, Enters Commercial Use

FDA Approves Durvalumab Added to Perioperative FLOT for Resectable Gastric and GEJ Cancer

FDA Clears Padcev Plus Keytruda Regimens as Perioperative Option for Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

Two Nature Studies Show FSP1 Blockade Triggers Ferroptosis and Shrinks Tumors in Mice

Spanish Dual-Target CAR-T With Low-Intensity Transplant Shows Promising Pediatric Survival

NICE Approves Darolutamide on the NHS in England for Advanced Prostate Cancer